Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism BTK C481S inhibitors(Bruton Tyrosine Kinase C481S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | IND Application | India | 30 Jan 2022 | |
| Diffuse Large B-Cell Lymphoma | Preclinical | India | - | |
| Rheumatoid Arthritis | Preclinical | India | - |





